Latest Insider Transactions at Castlight Health, Inc. (CSLT)
This section provides a real-time view of insider transactions for Castlight Health, Inc. (CSLT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CASTLIGHT HEALTH, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CASTLIGHT HEALTH, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2022
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
126,058
-100.0%
|
-
|
|
Feb 17
2022
|
Seth B. Cohen Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
208,712
-100.0%
|
-
|
|
Feb 17
2022
|
Michael L. Eberhard Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
425,809
-100.0%
|
-
|
|
Feb 17
2022
|
David A Ebersman Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
630,803
-100.0%
|
-
|
|
Feb 17
2022
|
David A Ebersman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,354
-100.0%
|
-
|
|
Feb 17
2022
|
Ed Park Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
405,184
-100.0%
|
-
|
|
Feb 17
2022
|
David B Singer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
405,184
-100.0%
|
-
|
|
Feb 17
2022
|
Venrock Associates V LP > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,255,264
-100.0%
|
-
|
|
Feb 17
2022
|
Bryan E Roberts Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,255,264
-100.0%
|
-
|
|
Feb 17
2022
|
Bryan E Roberts Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
405,184
-100.0%
|
-
|
|
Feb 17
2022
|
Kenny Van Zant Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
661,794
-100.0%
|
-
|
|
Feb 17
2022
|
Judith K. Verhave Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
351,516
-100.0%
|
-
|
|
Feb 17
2022
|
William Bondurant Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
355,661
-100.0%
|
-
|
|
Feb 17
2022
|
Maeve O'Meara Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,625,989
-100.0%
|
-
|
|
Nov 17
2021
|
William Bondurant Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,114
-5.85%
|
$22,114
$1.77 P/Share
|
|
Nov 17
2021
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,629
-5.71%
|
$7,629
$1.78 P/Share
|
|
Nov 17
2021
|
Maeve O'Meara Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
99,009
-5.74%
|
$99,009
$1.77 P/Share
|
|
Nov 16
2021
|
William Bondurant Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,574
+2.68%
|
-
|
|
Nov 16
2021
|
M.P. Eric Chan Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,626
+3.16%
|
-
|
|
Nov 16
2021
|
Maeve O'Meara Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
186,290
+1.84%
|
-
|
|
Oct 08
2021
|
Maeve O'Meara Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
5,000
+0.32%
|
-
|
|
Aug 17
2021
|
Maeve O'Meara Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
99,975
-6.12%
|
$99,975
$1.71 P/Share
|
|
Aug 17
2021
|
William Bondurant Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,781
-6.68%
|
$22,781
$1.71 P/Share
|
|
Aug 17
2021
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,739
-6.41%
|
$7,739
$1.71 P/Share
|
|
Aug 16
2021
|
Maeve O'Meara Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
186,292
+1.94%
|
-
|
|
Aug 16
2021
|
William Bondurant Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,824
+2.62%
|
-
|
|
Aug 16
2021
|
M.P. Eric Chan Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,625
+3.5%
|
-
|
|
Jul 12
2021
|
David A Ebersman Director |
BUY
Conversion of derivative security
|
Indirect |
260,973
+30.47%
|
-
|
|
Jun 30
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
50,000
-19.33%
|
$100,000
$2.6 P/Share
|
|
Jun 29
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
40,000
-13.4%
|
$80,000
$2.4 P/Share
|
|
Jun 10
2021
|
Bryan E Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.86%
|
-
|
|
Jun 10
2021
|
Michael L. Eberhard Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.24%
|
-
|
|
Jun 10
2021
|
David A Ebersman Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.86%
|
-
|
|
Jun 10
2021
|
Ed Park Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.86%
|
-
|
|
Jun 10
2021
|
David B Singer Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.86%
|
-
|
|
Jun 10
2021
|
Kenny Van Zant Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+9.65%
|
-
|
|
Jun 10
2021
|
Judith K. Verhave Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+16.75%
|
-
|
|
Jun 10
2021
|
Seth B. Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+19.15%
|
-
|
|
Jun 09
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
30,000
-11.62%
|
$60,000
$2.2 P/Share
|
|
Jun 07
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
40,000
-13.41%
|
$80,000
$2.05 P/Share
|
|
May 20
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
15,807
-5.03%
|
$15,807
$1.74 P/Share
|
|
May 17
2021
|
William Bondurant Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,750
-7.81%
|
$23,750
$1.61 P/Share
|
|
May 17
2021
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
9,885
-8.98%
|
$9,885
$1.61 P/Share
|
|
May 17
2021
|
Maeve O'Meara Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
76,439
-5.02%
|
$76,439
$1.61 P/Share
|
|
May 16
2021
|
William Bondurant Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,449
+2.61%
|
-
|
|
May 16
2021
|
M.P. Eric Chan Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,584
+4.09%
|
-
|
|
May 16
2021
|
Maeve O'Meara Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
186,290
+2.09%
|
-
|
|
May 12
2021
|
Michael L. Eberhard Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+4.7%
|
-
|
|
Feb 19
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
17,119
-5.17%
|
$17,119
$1.72 P/Share
|
|
Feb 17
2021
|
William Bondurant Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,676
-7.55%
|
$19,676
$1.89 P/Share
|